A highly significant increase in cell sizes was seen for all three tested cell lines ( Figure 3B, D, F ).
← all excerpts
NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.
1
—
—
A highly significant increase in cell sizes was seen for all three tested cell lines ( Figure 3B, D, F ).